Pharmaceutical Technology

JULY 26, 2022

This sales growth will be in line with a steadily increasing disease prevalence and the entrance of novel agents into the market. This correction of the fundamental mechanism that leads to the complexity of neurological and physical disorders in NPC patients will potentially lead to improved long-term outcomes.

Marketing 122

Marketing Transportation Leads Patients 122

pharmaphorum

JANUARY 10, 2023

Research by Treasure Data , a market leading enterprise customer data platform (CDP), shows that HCPs are increasingly turning to digital to research scientific information, new medications, and brands. billion by 2026, according to research by the Business Research Company. Capturing market share. billion in 2021 to $9.23

Marketing 98

Marketing Pharma Healthcare Healthcare 98

pharmaphorum

AUGUST 5, 2022

Innovent is responsible for developing the drug in China, picking up exclusive marketing rights there, with Sanofi in line for up to €80 million in milestone payments as well as royalties on sales if it gets approved. It is being tested in a wide range of solid tumours and lymphoma, alone and in combination with other drugs.

Side effects 87

Side effects Marketing Pharma Medicine 87

Clarivate

MAY 14, 2024

While initially developed to help regulate blood sugar levels, they have also been found to promote appetite suppression, leading to weight loss in patients. What’s leading to the boom in development of semaglutide biosimilars? Per recent Clarivate estimates, the therapeutic market for these drugs is valued at approximately $1.7

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

pharmaphorum

JANUARY 18, 2023

That pressure can lead to diagnostic errors, with a 2018 study suggesting that there are 40 million errors involving imaging worldwide every year. The business generated sales of €1.8 billion (approximately $1.9 billion) in 2021, around 10% of the group’s total healthcare revenues.

Medical 59

Medical Pharma Media Sales 59

Clarivate

OCTOBER 25, 2023

The initial list, which takes effect in 2026, has the potential to roil formularies since it includes a mix of high-volume, preferred brands and a group of high-cost specialty drugs for autoimmune conditions (psoriasis) and cancer. Part D cannot cover drugs covered under Part A or Part B , forcing them to be addressed separately.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

PM360

APRIL 7, 2023

Dan Renick The IRA presents market access teams with a unique opportunity to make recommendations to CMS regarding the evidence and methodology that will be applied in evaluating drugs for upcoming Medicare negotiations that will lead to price adjustments in 2026. Given the volume of 340B sales (13% of total U.S.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

Pharmaceutical Technology

JANUARY 10, 2023

billion in sales in 2019, increasing to $136.2 billion in 2029, with drug sales almost doubling at a compound annual growth rate (CAGR) of 11.5%. Mounjaro is forecast to compete for significant market share with semaglutide and also Lilly’s Trulicity (dulaglutide), reaching peak sales of $10.2

Marketing 52

Marketing Physicians Leads Sales 52

PM360

APRIL 7, 2023

Pharma, formulary decision-makers, and contracting specialists must now track exact dates when drugs became available, then track the difference between average sales price (ASP) and Maximum Fair Price (MFP) to ensure provider reimbursement is correct.”

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. Furthermore, the 2020 post-pandemic launches, for which we now have up to 21 months of sales, show continued average underperformance.

Doctors 59

Doctors Medicine Marketing Sales 59

pharmaphorum

JULY 5, 2022

Prior to this, he founded the industry-leading publication, pharmaphorum, in 2009, which also provides broader content communications and marketing services to enable more effective customer engagement.

Patients 94

Patients Medicine Marketing Recruitment 94

PM360

SEPTEMBER 21, 2023

GoodRx is the leading platform 2 with the highest unaided awareness and trust across patients, physicians, and pharmacists 3 that Americans—regardless of insurance status—use across many phases of their healthcare journey. United States Specialty Pharmaceuticals Market & Forecast 2020-2026,” BusinessWire, December 8, 2020.

Prescription 52

Prescription Medical Patients Distribution 52

Pharmaceutical Technology

JANUARY 16, 2023

The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. The entire pharma industry will be affected by the fallout.

Pharma 64

Pharma Pharmaceutical Manufacturing Marketing 64

Pharmaceutical Technology

JANUARY 16, 2023

The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. The entire pharma industry will be affected by the fallout.

Pharma 52

Pharma Pharmaceutical Manufacturing Marketing 52